Defense / Aerospace / National Security

Acquisition Criteria

Genenta’s defense and advanced manufacturing pillar will be built through the acquisition of multiple privately held businesses operating across defense, aerospace and security sectors. Through this integration, the Company will seek to enhance these businesses through operational upgrades, institutional-grade governance, and improved financial visibility. 

Valutation Arbitrage
The Genenta Science value creation model is based on multiple valuation arbitrage: acquiring companies at private market valuations, consolidating and accelerating their growth, and ultimately monetizing them through public market multiples through ownership in a Nasdaq-listed platform.
This approach unlocks significant hidden value, provides scalable exposure to mission-critical sectors, and generates superior returns in industries characterized by strong demand tailwinds and regulatory protection. Genenta is transitioning from a solely biotech business to an earnings and profits business.

ATC initial agreement signed in January 2026, wholly-owned subsidiary completed on May 29, 2026. Italian company operating as high-precision manufacturer of tactical rifles and special-forces weapon systems, and competition-grade sporting firearms.

June 25, 2026, Sòphia High Tech: entry at 19.9%, moving toward 51% (two-tranche structure). Italian company manufacturing critical parts for Europe's space and defense programs.
defense_supply_chain_s

Defense supply chain